Why the study?
Reducing lactate levels is crucial in acute cardiovascular disease, and disease-specific trends in blood lactate can provide accurate evaluations of patient condition.
The timeframe for lactate reduction varies significantly among acute cardiovascular diseases, taking approximately 30 hours for acute heart failure, 40 hours for aortic dissection, and 95 hours for ischemic heart disease.
Answers are grounded in this paper and cite their sources.
Lactate trend monitoring may refine acute CV disease prognosis; hypothesis-generating for disease-specific reduction timeframes.
In patients with acute cardiovascular disease, treatment aimed at reducing lactate levels is crucial for improving prognosis. Trends in blood lactate levels for each specific cardiovascular disease can provide an accurate evaluation of the patient's condition. We used functional data analysis with nonlinear mixed effects models to estimate the timeframe of lactate reduction in 3 cardiovascular diseases (acute heart failure, aortic dissection, and ischemic heart disease) by analyzing lactate trends.Among 1,816 patients admitted to the intensive care unit (ICU) or intensive cardiovascular care unit (ICCU) of St. Luke's International Hospital for cardiology or cardiovascular surgery from December 31, 2010, to June 31, 2020, 1,249 adults with a diagnosis of acute heart failure (39%), aortic dissection (24%), or ischemic heart disease (37%) were included in the present study. Using functional data analysis with nonlinear mixed effects models, our study estimated the timeframe of lactate reduction based on blood lactate level trends. Lactate reduction took 30 hours (95% CI, 23-37 hours) in patients with acute heart failure, 40 hours (95% CI, 33-47 hours) in patients with aortic dissection, and 95 hours (95% CI, 49-failed estimate) in patients with ischemic heart disease.We were able to estimate the timeframe of lactate reduction with different cardiovascular diseases. Recognizing the differences in lactate reduction may be useful in developing treatment plans tailored to each disease.
No takes yet. Share an insight, caveat, or question.
Nakashima et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: